Lonvi Biosciences professes to have invented an age-defying tablet that might prolong human existence up to 150 years by concentrating on what are known as ‘senescent cells’, although no tests have been carried out on humans. Share Article Share Article Facebook X LinkedIn Reddit Bluesky Email Copy Link Link copied Bookmark Comments
A Chinese start-up company states it has formulated a tablet within the laboratory environment which could potentially lengthen the typical human lifespan to 150 years.
Lonvi Biosciences maintains that its specific formulation aims at ‘senescent cells’ within the body, which are maturing cells that resist demise and instead remain, triggering inflammation and age-associated ailments.
Article continues below ADVERTISEMENT
The Shenzhen-based start-up is anything but understated concerning its creation, with CEO Ip Zhu confidently declaring: “This isn’t just any ordinary tablet. This represents the ultimate goal.”
The pivotal element of the tablet originates from grape seeds and has been evidenced to extend durations of existence in lab animals by postponing illnesses linked to maturing.
Scientists employed by Lonvi Biosciences consider that ingesting the tablet may aid individuals in living beyond 120 years, whilst commencing its consumption from birth could conceivably propel you past the 150-year threshold.
Article continues below ADVERTISEMENT
Long Covid breakthrough, keeping an eye on the Atlantic’s biggest shark, and how we know humans and Neanderthals locked lips – all this and more in our latest weird science newsletter
Article continues below ADVERTISEMENT The latest news from around the world Subscribe Invalid email
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. Read our Privacy Policy
Get More of Our News on Google
Set Daily Express as a ‘Preferred Source’ to get quicker access to the news you value.
The tablet employs procyanidin C1 (PCC1), a constituent separated from grape seeds. In tests on mice, Lonvi alleges that the treatment amplified total lifespan by 9.4%, featuring a striking 64% augmentation from the initial day of administration.
Lyu Qinghua, Lonvi’s chief technology officer, mentioned to The New York Times that reaching 150 is “absolutely plausible” and might be attainable “within a few years”.
China has boosted anti-ageing studies to a top national concern in recent times, with President Xi Jinping allegedly conversing on the subject matter with his Russian counterpart, Vladimir Putin.
The nation has grouped it alongside AI and biotechnology, and the longevity field has transitioned from peripheral to core.
Other commercial leaders are presently investing considerably. One Shanghai co-founder revealed to Vice that a decade prior “nobody in China” deliberated longevity – it was “exclusively wealthy Americans”.
Currently, there exists a burgeoning fascination (and funding) in progressing the science, with firms presenting everything from sickness prevention to improved cellular vitality.
Lonvi states its PCC1 capsule isn’t merely about extending lifespan, but enhancing quality of life, by lessening the degradation that accompanies maturing.
Presently, the investigation stays restricted to lab conditions, lacking human experiments to substantiate the assertions.